Nanobiotix S.A. NBTX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.59% | -85.50% | 0.43% | -255.51% | -7.85% |
| Total Depreciation and Amortization | -0.59% | 13.68% | -0.42% | -10.77% | 7.86% |
| Total Amortization of Deferred Charges | -5.56% | 50.00% | 0.00% | -- | -- |
| Total Other Non-Cash Items | -0.59% | 185.46% | -0.43% | 149.31% | -7.85% |
| Change in Net Operating Assets | 0.59% | 13.12% | 0.43% | -413.44% | 7.84% |
| Cash from Operations | 0.59% | -14.09% | 0.43% | 5.27% | -7.85% |
| Capital Expenditure | 0.60% | -62.44% | 0.44% | -166.51% | -7.86% |
| Sale of Property, Plant, and Equipment | -0.65% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 103.68% | 0.61% | -141.18% | -7.94% |
| Cash from Investing | 0.60% | -38.46% | 0.45% | -164.64% | -7.86% |
| Total Debt Issued | -- | -- | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | 4.67% | 0.00% | 9.78% | 0.00% |
| Issuance of Common Stock | 0.00% | 4,913.29% | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 185.40% | 0.00% | -486.90% | 0.00% |
| Cash from Financing | -0.59% | 91.03% | -0.43% | 1,564.98% | -7.84% |
| Foreign Exchange rate Adjustments | -0.60% | 252.13% | -0.45% | 122.62% | -7.82% |
| Miscellaneous Cash Flow Adjustments | 0.00% | -200.00% | 0.00% | 200.00% | -20.00% |
| Net Change in Cash | -0.59% | 144.16% | -0.43% | 217.85% | -7.85% |